NCT05976360View on ClinicalTrials.gov

A Study to Investigate the Pharmacokinetics, Tolerability and Safety of Two Different Dupilumab Drug Products in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

November 2, 2014

Primary Completion Date

January 17, 2015

Study Completion Date

January 17, 2015

Conditions
Healthy Volunteer
Interventions
DRUG

Dupilumab (SAR231893)

Injection solution, subcutaneous

DRUG

Dupilumab (SAR231893)

Injection solution, subcutaneous.

Trial Locations (2)

55144

Prism Research-Site Number:840002, Saint Paul

65802

Biokinetic Clinical Applications-Site Number:840003, Springfield

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Sanofi

INDUSTRY